Inno, Alessandro, Giuseppe Bogina, Giulio Settanni, Matteo Salgarello, Giovanni Foti, Carlo Pomari, Vincenzo Picece, and Stefania Gori. “First-Line Tepotinib for a Very Elderly Patient With Metastatic NSCLC Harboring MET Exon 14 Skipping Mutation and High PD-L1 Expression”. Drug Target Insights 17, no. 1 (October 6, 2023): 110–113. Accessed November 23, 2024. https://journals.aboutscience.eu/index.php/dti/article/view/2626.